Enveric Biosciences Statistics
Enveric Biosciences (SLZ0) Stock Statistics & Valuation Metrics
Total Valuation
Enveric Biosciences has a market cap or net worth of EUR 6.15M. The enterprise value is EUR 1.05M.
- Market Cap
- EUR 6.15M
- Enterprise Value
- EUR 1.05M
Share Statistics
Enveric Biosciences has 4,475,884 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 4,475,884
- Owned by Insiders
- 13.67%
- Owned by Institutions
- 2.04%
Financial Efficiency
Enveric Biosciences’s return on equity (ROE) is -2.90 and return on invested capital (ROIC) is -210.04%.
- Return on Equity (ROE)
- -2.90
- Return on Assets (ROA)
- -2.38
- Return on Invested Capital (ROIC)
- -210.04%
- Return on Capital Employed (ROCE)
- -2.10
- Revenue Per Employee
- 0
- Profits Per Employee
- -2.02M
- Employee Count
- 6
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Enveric Biosciences is -0.24. Enveric Biosciences’s PEG ratio is -0.00.
- PE Ratio
- -0.24
- PS Ratio
- 0.00
- PB Ratio
- 1.19
- Price to FCF
- -0.74
- Price to Operating Cash Flow
- -0.74
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Enveric Biosciences had revenue of 0 and earned -12.13M in profits. Earnings per share was -36.24.
- Revenue
- 0
- Gross Profit
- -200.86K
- Operating Income
- -8.77M
- Pretax Income
- -8.77M
- Net Income
- -12.13M
- EBITDA
- -8.57M
- Earnings Per Share (EPS)
- -36.24
Cash Flow
In the last 12 months, operating cash flow was -9.14M and capital expenditures 0, giving a free cash flow of -9.14M billion.
- Operating Cash Flow
- -9.14M
- Free Cash Flow
- -9.14M
- Free Cash Flow per Share
- -2.04
Dividends & Yields
Enveric Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -134.75%
- Earnings Yield
- -138.45%
Stock Price Statistics
- Beta
- -1.11
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 4.67
- 200-Day Moving Average
- 4.67
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Enveric Biosciences upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 12, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- ―
Financial Position
Enveric Biosciences as a current ratio of 5.38, with Debt / Equity ratio of 0.00%
- Current Ratio
- 5.38
- Quick Ratio
- 5.38
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.55
- Interest Coverage Ratio
- -82777.81
Taxes
In the past 12 months, Enveric Biosciences has paid 3.36M in taxes.
- Income Tax
- 3.36M
- Effective Tax Rate
- -0.38
Enterprise Valuation
Enveric Biosciences EV to EBITDA ratio is -0.13, with an EV/FCF ratio of -0.13.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.13
- EV to Free Cash Flow
- -0.13
- EV to Operating Cash Flow
- -0.13
Balance Sheet
Enveric Biosciences has EUR 5.61M in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 5.61M billion.
- Cash & Marketable Securities
- EUR 5.61M
- Total Debt
- EUR 0.00
- Net Cash
- EUR 5.61M
- Net Cash Per Share
- EUR 1.25
- Tangible Book Value Per Share
- EUR 1.28
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%

